Peter D Fitzsimmons bought $251k of MNRO
President and CEO at MONRO, INC.. 13,350 shares at an average of $18.80, traded Feb 3, 2026, filed Feb 5, 2026.
Score components
- +25RoleCEO
- +13Trade size$251k at market
- +3Relative to holdingsHoldings up 16%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.6%, 3m -12.4%, 6m -36.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-039259, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 3, 2026 | POpen-market purchase Common Stock | +13,350 | $18.80 | $251k | 99,283 | Feb 5, 2026 |
Related signals
Other insiders at MONRO, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | MNRObuy MONRO, INC. | Peter D Fitzsimmons President and CEO | $251k 12,750 shares | +13% | |
| 50Moderate | MNRObuy MONRO, INC. | Carl C Icahn owner | $11M 638,659 shares | +14% | |
| 45Moderate | MNRObuy MONRO, INC. | Carl C Icahn owner | $9.7M 639,473 shares | +17% | |
| 47Moderate | MNRObuy MONRO, INC. | Michael T Broderick CEO & President | $161k 5,000 shares | +6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.